Summary
MEDI3S is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €89,650 and a net result of €41,377. Equity is growing by about 82% per year across the filed financial years. Its solvency ranks better than 81% of 9,732 sector peers (NACE 64, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
04-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2023 to 2025net €41,377 ▲8.4%
Operating result €56,615, net result €41,377, both a record.
03-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
15-01
Gazette deed
Appointment: Ine Janssens (director)2 facts ▸
Gazette deed
Appointment: Ine Janssens (director)
2 facts ▸
- General meeting, 01-11-2024
- Director appointment, Ine Janssens (director)
2024
31-12
Financial
Liquidity more than doubledcurrent ratio 3.83
Current ratio from 1.65 to 3.83.
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
13-03
Gazette deed
IncorporationAppointment: HINOUL Tom Elisa François Eddy Hilly (director) · Founder · Founding capital6 facts ▸
Gazette deed
Incorporation
Appointment: HINOUL Tom Elisa François Eddy Hilly (director) · Founder · Founding capital6 facts ▸
- Incorporation, “MEDI3S” (deed in Dutch)
- Founder, HINOUL Tom Elisa François Eddy Hilly
- Founding capital, €3,000
- Board rule, 1
- Director appointment, HINOUL Tom Elisa François Eddy Hilly (director)
- Registered office clause, “3960 Bree, Cobbenberg 19” (deed in Dutch)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 2 deeds read